The advent of amyloid-β (Aβ) and tau PET imaging has revolutionized Alzheimer disease (AD) research, enabling in vivo ...

Radiotheranostics refers to dual diagnostic–therapeutic capacity that allows for precision medicine at an unprecedented level, reducing collateral toxicity and improving patient outcomes ([1][1]). In ...

The coronavirus disease 2019 (COVID-19) pandemic underscored the need for the development of tools that can visualize immune system activity in the context of viral inflammation. Although [18F]FDG PET ...

Journal of Nuclear Medicine September 2025, jnumed.125.269539; DOI: https://doi.org/10.2967/jnumed.125.269539 ...

Journal of Nuclear Medicine August 2025, jnumed.124.269234; DOI: https://doi.org/10.2967/jnumed.124.269234 ...

Journal of Nuclear Medicine July 2025, jnumed.125.269640; DOI: https://doi.org/10.2967/jnumed.125.269640 ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252173; ...

The study of the human phenome is essential for understanding the complexities of wellness and disease and their transitions, with molecular imaging being a vital tool in this exploration. Molecular ...

Journal of Nuclear Medicine April 2025, jnumed.124.268980; DOI: https://doi.org/10.2967/jnumed.124.268980 ...

Journal of Nuclear Medicine April 2025, jnumed.124.269064; DOI: https://doi.org/10.2967/jnumed.124.269064 ...

Nectin cell adhesion molecule 4 (Nectin-4) is an emerging biomarker for cancer diagnosis and therapy. We developed a Nectin-4–targeted 68Ga-DOTA-Sar10-Nectin-4 (68Ga-FZ-NR-1) PET/CT radiotracer for ...

Journal of Nuclear Medicine September 2024, jnumed.124.268020; DOI: https://doi.org/10.2967/jnumed.124.268020 ...